All articles by Manish Kumar
Balt raises €355m to refinance debt and boost growth plans
The financing, provided by a group of institutional investors and banks, represents a key milestone in Balt’s plans to enhance operations and advance its product development strategy
AVITA Medical receives FDA 510(k) clearance for Cohealyx dermal matrix
Cohealyx aims to enhance tissue integration and revascularisation to accelerate wound healing, reduce treatment times, and improve outcomes for full-thickness wound treatment
Lucid joins forces with VITALExam to offer EsoGuard test to firefighters
VITALExam provides medical care, including cancer screenings, physicals, and behavioural health assessments, using advanced technology to optimise first responders’ wellness
ONWARD Medical receives FDA de novo classification and US market authorisation for world’s first non-invasive spinal cord stimulation system
ARC-EX System is the first and only FDA approved technology shown to improve hand strength and sensation after chronic spinal cord injury
Axoft to begin brain implant clinical study, marking the first time bio-inspired material is authorised for use in humans
The company and The Panama Clinic are partnering to show that soft, neural implants can safely decode human brain signals
Hologic partners with US CDC to develop ASRs for H5N1 bird flu detection
The contract will support the development of ASRs for H5N1 detection on the automated Panther Fusion system for potential use in laboratory-developed tests
Mevion gets Chinese nod for MEVION S250i Proton Therapy System
The system is equipped with a superconducting proton accelerator integrated into a compact gantry, resulting in a smaller footprint and lower energy consumption compared to conventional proton therapy systems
DuraStat launches commercial partnership with Medtronic cranial and spinal technologies business
DuraStat is a medical device company based in Austin, TX focused on unique approaches to precision surgical suturing, enabling fast, atraumatic tissue approximation by eliminating wrist rotation
Pharus Diagnostics announces validation of a laboratory-developed test for early pancreatic cancer detection
The test uses a simple blood sample, next-generation sequencing, and a proprietary machine learning pipeline to analyze levels of microRNA and CA19-9 biomarkers
Quanterix to acquire bead technology firm EMISSION for up to $70m
EMISSION’s proprietary bead technology will be integrated into Quanterix’s next-gen platform and used to develop a new multi-plex segment for third-party customers